Rapid drug screening with patient-derived organoids to drive personalized medicine

29 January 2020

In this video, Dr. David Donner, Director of the Surgical Oncology Research Lab at the University of California, San Francisco (UCSF) discusses the research taking place at the Surgical Oncology Research Laboratory at UCSF, and explains how he uses drug dispensing technology* and patient-derived organoids to enable vital research into liver malignancies, specifically metastatic colorectal cancer that has metastasized into the liver and intrahepatic cholangiocarcinoma. Donner also offers an insight into the challenges and future of personalized medicine. 

*For research use only. Not for use in diagnostic procedures. Tecan D300e Digital Dispenser is a product of HP Inc. CA, USA.